These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 29663878)

  • 1. Role of Angiogenic Growth Factors in Psoriasis: A Review.
    Akhtar T; Wani WY; Kamal MA; Kaur R
    Curr Drug Metab; 2018; 19(11):910-916. PubMed ID: 29663878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiogenesis drives psoriasis pathogenesis.
    Heidenreich R; Röcken M; Ghoreschi K
    Int J Exp Pathol; 2009 Jun; 90(3):232-48. PubMed ID: 19563608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant production of interleukin-8 and thrombospondin-1 by psoriatic keratinocytes mediates angiogenesis.
    Nickoloff BJ; Mitra RS; Varani J; Dixit VM; Polverini PJ
    Am J Pathol; 1994 Apr; 144(4):820-8. PubMed ID: 7512793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous vascular patterns in psoriasis.
    Micali G; Lacarrubba F; Musumeci ML; Massimino D; Nasca MR
    Int J Dermatol; 2010 Mar; 49(3):249-56. PubMed ID: 20465659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of lymphocyte-dependent angiogenesis using a SCID mouse: human skin model of psoriasis.
    Nickoloff BJ
    J Investig Dermatol Symp Proc; 2000 Dec; 5(1):67-73. PubMed ID: 11147678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiogenesis--a new target for future therapy.
    Pandya NM; Dhalla NS; Santani DD
    Vascul Pharmacol; 2006 May; 44(5):265-74. PubMed ID: 16545987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular proliferation and angiogenic factors in psoriasis.
    Creamer JD; Barker JN
    Clin Exp Dermatol; 1995 Jan; 20(1):6-9. PubMed ID: 7545558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical application of anti-angiogenic peptides based on pigment epithelium-derived factor can improve psoriasis.
    Abe R; Yamagishi S; Fujita Y; Hoshina D; Sasaki M; Nakamura K; Matsui T; Shimizu T; Bucala R; Shimizu H
    J Dermatol Sci; 2010 Mar; 57(3):183-91. PubMed ID: 20060688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular endothelial growth factor (VEGF) in the pathogenesis of psoriasis--a possible target for novel therapies?
    Canavese M; Altruda F; Ruzicka T; Schauber J
    J Dermatol Sci; 2010 Jun; 58(3):171-6. PubMed ID: 20430590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
    Gacche RN; Meshram RJ
    Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psoriasin (S100A7) promotes stress-induced angiogenesis.
    Vegfors J; Ekman AK; Stoll SW; Bivik Eding C; Enerbäck C
    Br J Dermatol; 2016 Dec; 175(6):1263-1273. PubMed ID: 27155199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased endothelemia as an indirect marker of changes in the blood vessel endothelium in psoriasis.
    Sochorova R; Svecova D; Sinka L; Rybarova L
    J Eur Acad Dermatol Venereol; 2004 Sep; 18(5):556-9. PubMed ID: 15324392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-214 inhibits angiogenesis by targeting Quaking and reducing angiogenic growth factor release.
    van Mil A; Grundmann S; Goumans MJ; Lei Z; Oerlemans MI; Jaksani S; Doevendans PA; Sluijter JP
    Cardiovasc Res; 2012 Mar; 93(4):655-65. PubMed ID: 22227154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of pro-angiogenic genes in mesenchymal stem cells derived from dermis of patients with psoriasis.
    Niu X; Chang W; Liu R; Hou R; Li J; Wang C; Li X; Zhang K
    Int J Dermatol; 2016 May; 55(5):e280-8. PubMed ID: 26748901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histological and transcriptional study of angiogenesis and lymphangiogenesis in uninvolved skin, acute pinpoint lesions and established psoriasis plaques: an approach of vascular development chronology in psoriasis.
    Henno A; Blacher S; Lambert CA; Deroanne C; Noël A; Lapière C; de la Brassinne M; Nusgens BV; Colige A
    J Dermatol Sci; 2010 Mar; 57(3):162-9. PubMed ID: 20071151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiogenesis and lymphangiogenesis in inflammatory skin disorders.
    Varricchi G; Granata F; Loffredo S; Genovese A; Marone G
    J Am Acad Dermatol; 2015 Jul; 73(1):144-53. PubMed ID: 25922287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiogenesis in psoriatic skin and its modifications after administration of etanercept: videocapillaroscopic, histological and immunohistochemical evaluation.
    Campanati A; Goteri G; Simonetti O; Ganzetti G; Giuliodori K; Giuliano A; Sabato S; Stramazzotti D; Gulini E; Dusi D; De Blasio S; Fabris G; Offidani A
    Int J Immunopathol Pharmacol; 2009; 22(2):371-7. PubMed ID: 19505391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Very late antigen-1 in psoriasis: an immunohistochemical study.
    Baum S; Barzilai A; Huszar M; Greenberger S; Trau H; Bank I
    J Eur Acad Dermatol Venereol; 2008 Mar; 22(3):283-9. PubMed ID: 18269595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiogenesis and oxidative stress: common mechanisms linking psoriasis with atherosclerosis.
    Armstrong AW; Voyles SV; Armstrong EJ; Fuller EN; Rutledge JC
    J Dermatol Sci; 2011 Jul; 63(1):1-9. PubMed ID: 21600738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal dermal microvascular endothelial cells in psoriatic excessive angiogenesis.
    Hou H; Li J; Wang J; Hou R; Li J; Zhang K
    Microvasc Res; 2024 Sep; 155():104718. PubMed ID: 39019108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.